Published in Curr Opin Oncol on July 01, 2004
Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report. J Transl Med (2009) 0.88
Recent advances and significance of intra-arterial infusion chemotherapy in non-resectable colorectal liver metastasis. J Gastrointest Oncol (2013) 0.79
The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study. Invest New Drugs (2007) 0.77
International network of cancer genome projects. Nature (2010) 20.35
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet (2007) 11.62
Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial. BMJ (2004) 7.01
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet (2008) 6.97
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet (2008) 6.26
Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care (2006) 6.25
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol (2005) 6.20
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet (2007) 6.02
Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer (2009) 3.99
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet (2007) 3.93
Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol (2011) 3.67
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol (2005) 3.48
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J Clin Oncol (2010) 3.30
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer. Clin Cancer Res (2009) 3.08
Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care (2011) 2.83
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol (2007) 2.41
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. J Clin Oncol (2014) 2.17
KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer. Clin Cancer Res (2011) 1.87
Bevacizumab--current status and future directions. Ann Oncol (2005) 1.78
Preventing childhood obesity: two year follow-up results from the Christchurch obesity prevention programme in schools (CHOPPS). BMJ (2007) 1.71
Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol (2003) 1.66
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut (2012) 1.52
Neural networks in the prediction of survival in patients with colorectal cancer. Clin Colorectal Cancer (2003) 1.51
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol (2011) 1.50
Consensus pathways: evidence into practice. N Z Med J (2015) 1.48
Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab (2002) 1.48
Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. Hum Mol Genet (2008) 1.40
Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study. Lancet Oncol (2008) 1.39
Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes. Hum Mol Genet (2011) 1.33
Diabetes Interactive Diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized study. Diabetes Care (2009) 1.31
Deciphering the roles of the histone H2B N-terminal domain in genome-wide transcription. Mol Cell Biol (2006) 1.28
Comprehensive assessment of variation at the transforming growth factor beta type 1 receptor locus and colorectal cancer predisposition. Proc Natl Acad Sci U S A (2010) 1.16
Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations. Am J Gastroenterol (2013) 1.12
Use of multivariate analysis to suggest a new molecular classification of colorectal cancer. J Pathol (2013) 1.09
Immunorelevant gene expression in LPS-challenged bovine mammary epithelial cells. J Appl Genet (2005) 1.06
Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. Hum Mol Genet (2009) 1.03
Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care (2012) 1.00
Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans. Circulation (2011) 1.00
A new model for cancer research in France. Nat Rev Cancer (2006) 0.98
Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study. Diabetes Care (2009) 0.98
Ketamine and cancer pain: the reports of my death have been greatly exaggerated. J Clin Oncol (2013) 0.96
Future artificial pancreas technology for type 1 diabetes: what do users want? Diabetes Technol Ther (2015) 0.95
Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN. Oncotarget (2012) 0.94
Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future. Expert Rev Anticancer Ther (2007) 0.92
Poor numeracy: the elephant in the diabetes technology room. J Diabetes Sci Technol (2010) 0.91
Central and peripheral effects of sustained caffeine use: tolerance is incomplete. Br J Clin Pharmacol (2002) 0.91
Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice. Diabetes Metab Res Rev (2002) 0.89
Influence of caffeine on heart rate variability in patients with long-standing type 1 diabetes. Diabetes Care (2004) 0.88
Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J (2006) 0.86
Engaging health professional students in substance abuse research: development and early evaluation of the SARET program. J Addict Med (2012) 0.86
Biochemical characterization of P4-ATPase mutations identified in patients with progressive familial intrahepatic cholestasis. J Biol Chem (2012) 0.85
Biomarkers in early-stage colorectal cancer: ready for prime time? Dig Dis (2012) 0.84
Effects of simulated altitude on blood glucose meter performance: implications for in-flight blood glucose monitoring. J Diabetes Sci Technol (2012) 0.84
Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care (2005) 0.84
Glucose intolerance during adjuvant chemotherapy for breast cancer. J Natl Cancer Inst (2009) 0.83
Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patients. J Hum Genet (2010) 0.82
Microbial resolution of baclofen by a new isolate of Streptomyces halstedii. J Biosci Bioeng (2002) 0.81
Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial glucose monitoring system in patients with long-standing type 1 diabetes. Diabetes Care (2005) 0.81
Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1). Eur J Cancer (2008) 0.81
Longitudinal monitoring of two commercial layer flocks and their environments for Salmonella enterica serovar enteritidis and other Salmonellae. Avian Dis (2005) 0.80
Fifth revision of Declaration of Helsinki. Clause 29 forbids trials from using placebos when effective treatment exists. BMJ (2002) 0.79
Influence of local skin temperature and choice of insulin analog on catheter occlusion rates during continuous insulin infusion: an exploratory study. Diabetes Technol Ther (2012) 0.79
Fluorescence studies of the intra-cellular distribution of zinc bis(thiosemicarbazone) complexes in human cancer cells. Chem Commun (Camb) (2005) 0.78
High-speed dynamic speckle interferometry: phase errors due to intensity, velocity, and speckle decorrelation. Appl Opt (2005) 0.78
Self-monitoring of blood glucose and type 2 diabetes: new tricks for the old dog? J Diabetes Sci Technol (2011) 0.78
Lactation induction as a predictor of post-parturition transgene expression in bovine milk. J Dairy Res (2007) 0.77
Modelling the effect of alcohol in Type 1 diabetes. Stud Health Technol Inform (2002) 0.77
Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial). BMC Endocr Disord (2012) 0.77
Impact of Familial Factors and Psychopathology on Suicidality Among African American Adolescents. J Hum Behav Soc Environ (2007) 0.77
Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer. Sci Rep (2015) 0.76
Using insulin in type 2 diabetes: in need of a renaissance? J Diabetes Sci Technol (2011) 0.75
Targeted therapies: Manufacturer sponsorship bias in economic analyses matters. Nat Rev Clin Oncol (2012) 0.75
Nutrition, physical activity, and obesity. Lancet (2002) 0.75
Sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med (2010) 0.75
Overweight children and adolescents. N Engl J Med (2005) 0.75
Reversible blindness: severe pneumococcal induced uveitis following septicaemia. BMJ Case Rep (2011) 0.75
Involving patients can work in home blood glucose testing. BMJ (2003) 0.75
The effect of alcohol on blood glucose in Type 1 diabetes--metabolic modelling and integration in a decision support system. Int J Med Inform (2003) 0.75
Measuring caffeine-induced changes in middle cerebral artery blood velocity using transcranial Doppler in patients recovering from ischaemic stroke. Physiol Meas (2002) 0.75
Passing judgement on Lansley's vision. Health Serv J (2011) 0.75
Biomarkers in clinical medicine. IARC Sci Publ (2011) 0.75